BRIEF published on 11/19/2024 at 20:52, 1 day 14 hours ago Danone: Update on voting rights and shares as of October 31, 2024 Share Capital Voting Rights Crossing Thresholds AMF Regulation Danone Shares
PRESS RELEASE published on 11/19/2024 at 20:47, 1 day 14 hours ago Danone: Information on the total number of voting rights and shares Danone discloses information on total voting rights and shares in compliance with French regulations. Details on theoretical and exercisable voting rights provided Voting Rights Shares French Regulations Danone Total Number
BRIEF published on 09/11/2024 at 18:26, 2 months 9 days ago Danone: Information on the Total Number of Voting Rights and Shares Voting Rights Shares AMF Financial Markets Danone
PRESS RELEASE published on 09/11/2024 at 18:21, 2 months 9 days ago Danone: Information on the total number of voting rights and shares Danone provides information on total number of voting rights and shares, in compliance with French regulations. Details on theoretical and exercisable voting rights included Voting Rights Shares French Regulations AMF Danone
BRIEF published on 08/06/2024 at 17:52, 3 months 14 days ago DANONE: Information on voting rights and shares Share Capital Voting Rights Actions AMF Danone
PRESS RELEASE published on 08/06/2024 at 17:47, 3 months 14 days ago Danone: Information on the total number of voting rights and shares French company DANONE discloses total voting rights and shares information in compliance with French commercial regulations Voting Rights French Company Shares Compliance Danone
PRESS RELEASE published on 07/31/2024 at 07:31, 3 months 21 days ago Danone: Strong half-year results; Delivering broad-based quality growth Danone reports strong half-year results with net sales reaching €13,757m, up +4.0% like-for-like. Recurring operating margin up +45 bps to 12.69%. 2024 guidance confirms +3% to +5% sales growth Net Sales 2024 Guidance Half-year Results Recurring Operating Margin Danone
BRIEF published on 06/20/2024 at 07:56, 5 months 1 day ago Danone opens a new strategic chapter for 2025-2028 Strategy Growth Nutrition Health Danone
PRESS RELEASE published on 06/20/2024 at 07:51, 5 months 1 day ago Danone opens the next chapter of its Renew strategy ; Projecting the company into the future of Health and Nutrition Danone unveils its mid-term strategy at Capital Market Event, focusing on Health and Nutrition future with science-based approach and expanded business models Business Models Danone Capital Market Event Mid-term Strategy Health And Nutrition
Published on 11/21/2024 at 10:03, 53 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 56 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 56 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 21 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 31 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 26 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 51 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 53 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 56 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 56 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 58 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 36 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 11 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 11 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo